IL118573A - Pharmaceutical compositions for minimizing bone loss - Google Patents

Pharmaceutical compositions for minimizing bone loss

Info

Publication number: IL118573A
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; bone loss; minimizing bone; minimizing; loss
Prior art date: 1995-06-06

Application number

IL11857396A

Other languages

English (en)

Other versions

IL118573A0 (en

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1996-06-05

Publication date

2000-01-31

1996-06-05 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1996-10-16 Publication of IL118573A0 publication Critical patent/IL118573A0/xx

2000-01-31 Publication of IL118573A publication Critical patent/IL118573A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

IL11857396A 1995-06-06 1996-06-05 Pharmaceutical compositions for minimizing bone loss IL118573A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US47111195A	1995-06-06	1995-06-06

Publications (2)

Publication Number	Publication Date
IL118573A0 IL118573A0 (en)	1996-10-16
IL118573A true IL118573A (en)	2000-01-31

Family

ID=23870302

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11857396A IL118573A (en)	1995-06-06	1996-06-05	Pharmaceutical compositions for minimizing bone loss

Country Status (27)

Country	Link
EP (1)	EP0747056B1 (xx)
JP (1)	JP2001501907A (xx)
KR (1)	KR19990022497A (xx)
CN (1)	CN1239429A (xx)
AR (2)	AR003134A1 (xx)
AT (1)	ATE187643T1 (xx)
AU (1)	AU696927B2 (xx)
BR (1)	BR9608390A (xx)
CA (1)	CA2223174A1 (xx)
CO (1)	CO4700447A1 (xx)
CZ (1)	CZ383097A3 (xx)
DE (1)	DE69605600T2 (xx)
DK (1)	DK0747056T3 (xx)
EA (1)	EA199800014A1 (xx)
ES (1)	ES2142545T3 (xx)
GR (1)	GR3032863T3 (xx)
HU (1)	HUP9900854A3 (xx)
IL (1)	IL118573A (xx)
NO (1)	NO975560L (xx)
PE (1)	PE2298A1 (xx)
PL (1)	PL323941A1 (xx)
PT (1)	PT747056E (xx)
SI (1)	SI0747056T1 (xx)
TR (1)	TR199701508T1 (xx)
WO (1)	WO1996039141A1 (xx)
YU (1)	YU34296A (xx)
ZA (1)	ZA964681B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001509010A (ja) *	1996-11-22	2001-07-10	アクゾ・ノベル・エヌ・ベー	Ｂｍｐ―４プロモーターならびに骨粗鬆症の予防および／または治療用の治療剤のスクリーニングにおけるその用途
GB2324726A (en) *	1997-05-01	1998-11-04	Merck & Co Inc	Combination Therapy for the Treatment of Osteoporosis
US6096764A (en) *	1997-08-21	2000-08-01	Eli Lilly And Company	Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4895715A (en) *	1988-04-14	1990-01-23	Schering Corporation	Method of treating gynecomastia
US5393785A (en) *	1988-10-31	1995-02-28	Endorecherche, Inc.	Therapeutic antiestrogens
US5482949A (en) *	1993-03-19	1996-01-09	Eli Lilly And Company	Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
DE4329344A1 (de) *	1993-08-27	1995-03-02	Schering Ag	Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri

1996
- 1996-05-30 PT PT96303874T patent/PT747056E/pt unknown
- 1996-05-30 EP EP96303874A patent/EP0747056B1/en not_active Expired - Lifetime
- 1996-05-30 ES ES96303874T patent/ES2142545T3/es not_active Expired - Lifetime
- 1996-05-30 DE DE69605600T patent/DE69605600T2/de not_active Expired - Fee Related
- 1996-05-30 SI SI9630163T patent/SI0747056T1/xx unknown
- 1996-05-30 DK DK96303874T patent/DK0747056T3/da active
- 1996-05-30 AT AT96303874T patent/ATE187643T1/de not_active IP Right Cessation
- 1996-06-05 AU AU59816/96A patent/AU696927B2/en not_active Ceased
- 1996-06-05 PL PL96323941A patent/PL323941A1/xx unknown
- 1996-06-05 HU HU9900854A patent/HUP9900854A3/hu unknown
- 1996-06-05 AR ARP960102930A patent/AR003134A1/es not_active Application Discontinuation
- 1996-06-05 CN CN96195984A patent/CN1239429A/zh active Pending
- 1996-06-05 KR KR1019970708978A patent/KR19990022497A/ko not_active Application Discontinuation
- 1996-06-05 JP JP09501298A patent/JP2001501907A/ja active Pending
- 1996-06-05 BR BR9608390A patent/BR9608390A/pt not_active Application Discontinuation
- 1996-06-05 PE PE1996000409A patent/PE2298A1/es not_active Application Discontinuation
- 1996-06-05 CZ CZ973830A patent/CZ383097A3/cs unknown
- 1996-06-05 CO CO96029179A patent/CO4700447A1/es unknown
- 1996-06-05 TR TR97/01508T patent/TR199701508T1/xx unknown
- 1996-06-05 YU YU34296A patent/YU34296A/sr unknown
- 1996-06-05 ZA ZA9604681A patent/ZA964681B/xx unknown
- 1996-06-05 IL IL11857396A patent/IL118573A/xx not_active IP Right Cessation
- 1996-06-05 WO PCT/US1996/008810 patent/WO1996039141A1/en not_active Application Discontinuation
- 1996-06-05 AR ARP960102931A patent/AR003002A1/es not_active Application Discontinuation
- 1996-06-05 EA EA199800014A patent/EA199800014A1/ru unknown
- 1996-06-05 CA CA002223174A patent/CA2223174A1/en not_active Abandoned
1997
- 1997-12-02 NO NO975560A patent/NO975560L/no unknown
2000
- 2000-03-03 GR GR20000400555T patent/GR3032863T3/el unknown

Also Published As

Publication number	Publication date
CO4700447A1 (es)	1998-12-29
KR19990022497A (ko)	1999-03-25
NO975560L (no)	1998-01-26
NO975560D0 (no)	1997-12-02
PT747056E (pt)	2000-05-31
AU696927B2 (en)	1998-09-24
YU34296A (en)	1999-11-22
CN1239429A (zh)	1999-12-22
AR003134A1 (es)	1998-07-08
WO1996039141A1 (en)	1996-12-12
ATE187643T1 (de)	2000-01-15
ES2142545T3 (es)	2000-04-16
BR9608390A (pt)	1999-05-04
PL323941A1 (en)	1998-04-27
EP0747056A2 (en)	1996-12-11
CZ383097A3 (cs)	1998-09-16
EA199800014A1 (ru)	1998-06-25
DE69605600T2 (de)	2000-05-31
EP0747056B1 (en)	1999-12-15
DE69605600D1 (de)	2000-01-20
GR3032863T3 (en)	2000-07-31
AR003002A1 (es)	1998-05-27
TR199701508T1 (xx)	1998-03-21
CA2223174A1 (en)	1996-12-12
JP2001501907A (ja)	2001-02-13
PE2298A1 (es)	1998-02-28
SI0747056T1 (en)	2000-06-30
HUP9900854A3 (en)	2000-03-28
ZA964681B (en)	1997-12-05
AU5981696A (en)	1996-12-24
EP0747056A3 (en)	1997-03-05
DK0747056T3 (da)	2000-05-01
IL118573A0 (en)	1996-10-16
HUP9900854A2 (hu)	1999-08-30

Publication	Publication Date	Title
ZA957247B (en)	1997-02-28	Pharmaceutical compositions
HUP9802086A3 (en)	2001-02-28	Pharmaceutical composition for piperidinoalkanol compounds
ZA967827B (en)	1997-03-18	Pharmaceutical compositions
IL118590A (en)	1999-10-28	Pharmaceutical composition for minimizing bone loss
IL113329A0 (en)	1995-07-31	Benzamide-containing pharmaceutical compositions
GB9418609D0 (en)	1994-11-02	Pharmaceutical compositions
EG24294A (en)	2009-01-08	Pharmaceutical compositions
GB9506382D0 (en)	1995-05-17	Pharmaceutical compositions
GB9513972D0 (en)	1995-09-06	Pharmaceutical compositions
ZA96525B (en)	1996-08-06	Novel pharmaceutical compositions
ZA954469B (en)	1996-01-24	Pharmaceutical compositions
ZA959081B (en)	1997-04-29	Pharmaceutical compositions
IL118573A (en)	2000-01-31	Pharmaceutical compositions for minimizing bone loss
GB9406835D0 (en)	1994-06-01	Pharmaceutical compositions
GB2295825B (en)	1997-01-29	Pharmaceutical compositions
HU9601821D0 (en)	1996-09-30	Pharmaceutical compositions
HU9400096D0 (en)	1994-05-30	Pharmaceutical compositions
HUP0003528A3 (en)	2001-07-30	Pharmaceutical compositions containing dihydropolyprenols
GB2285923B (en)	1997-11-19	Pharmaceutical compositions containing N-acetal-cysteine
HK1087642A1 (en)	2006-10-20	Sterile pharmaceutical composition
GB9707483D0 (en)	1997-05-28	Pharmaceutical compositions
GB9505164D0 (en)	1995-05-03	Pharmaceutical compositions
HU0500763D0 (en)	2005-10-28	Pharmaceutical compositions
GB9519157D0 (en)	1995-11-22	Pharmaceutical compositions
GB9517133D0 (en)	1995-10-25	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2000-06-29	FF	Patent granted
2003-03-12	MM9K	Patent not in force due to non-payment of renewal fees